EPIC ORDER CODE LAB3200 MVista Histoplasma Ag Quantitative EIA
Additional Codes
SQ: FHST
Reporting Name
MVista Histoplasma AntigenPerforming Laboratory
MiraVista DiagnosticsSpecimen Type
VariesSpecimen Required
Submit only 1 of the following specimens:
Bronchial Washing
Collect 2 mL of Bronchial Washing in leak proofed container.
Ship refrigerate.
Required:
1. Label specimen appropriately (Bronchial Washing)
Body Fluid
Collect 2 mL of Body Fluid in leak proofed container.
Ship refrigerate.
Required:
1. Label specimen appropriately (Type of Body Fluid)
Note: MiraVista will test most body fluids with the following disclaimer: The reference range and other method performance specifications have not been established for this test in this type of Body Fluid. The test results should be integrated into the clinical context for interpretation.
Note:Â Minimum volume does not allow for repeats.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Refrigerated (preferred) | 14 days | |
Ambient | 14 days | ||
Frozen |
Reference Values
Reference interval: None Detected
Reportable Range: Positive Results reported in ng/mL from 0.20 ng/mL to 20.00 ng/mL
Positive Results above 20.00 ng/mL are reported as “Above the Limit of Quantificationâ€.
Day(s) Performed
Monday through Friday
CPT Code Information
87385
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
FHST | MVista Histoplasma Antigen | 57766-8 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
Z1746 | Specimen Type | 31208-2 |
Z1747 | Result | 57766-8 |
Z1748 | Interpretation | 59464-8 |
Report Available
3 to 5 daysReject Due To
Other | Specimen that is too viscous to pipette. Tissue, biopsy, sputum, bronchial brush, tracheal aspirate, FNA, bone marrow aspirate, stool or samples in transport media, fixative or Isolator tubes |
Test Classification
This test was developed and its performance characteristics determined by MiraVista Diagnostics. It has not been cleared or approved by the FDA; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.Method Name
Quantitative Sandwich Enzyme Immunoassay (EIA)